Tag: Cancer: Lung
Surgery Can Benefit ‘Ineligible’ High-Risk Lung Cancer Patients
May be a treatment option for patients previously deemed ineligible
CRT May Be Preferred Strategy for Elderly With Lung Cancer
Increased survival for chemoradiotherapy versus chemotherapy in limited-stage, small-cell lung cancer
Report Details Benefits, Risks of Nivolumab for Squamous NSCLC
Benefit-risk summary shows beneficial effects for patients with metastatic SQ NSCLC
FDA Approves Expanded Use of Opdivo in Advanced Lung Cancer
Demonstrates survival benefit in both squamous and non-squamous non-small-cell lung cancer
Most Cancer Patients Believe Surgery Will Be Curative
Findings even among patients with stage IV lung, colorectal cancer
Palliative Radiotherapy Often Overused in Stage IV NSCLC
Not proven to further improve symptoms or quality of life; can have significant side effects
FDA Approves Keytruda for Advanced NSCLC
Approved for use with PD-L1 IHC 22C3 pharmDx test
Differences Found in Smokers, Nonsmokers Who Develop NSCLC
Nonsmokers more likely than smokers to be women and to have adenocarcinoma
CT Scans for Lung Cancer Result in Few False-Positives
Concerns that wider adoption of the screen might lead to unnecessary surgeries are unfounded
New Treatment Option for Some With Metastatic Lung Cancer
Nivolumab found most effective in tumors expressing programmed death-ligand 1
